Literature DB >> 12052633

Hypertonic sabouraud broth as a simple and powerful test for Candida dubliniensis screening.

Sydney Hartz Alves1, Eveline Pipolo Milan, Priscilla de Laet Sant'Ana, Loiva O Oliveira, Janio M Santurio, Arnaldo Lopes Colombo.   

Abstract

We developed a new screening test for C. dubliniensis based on its inability to grow on Sabouraud dextrose broth with 6.5% NaCl. A total of 266 clinical yeast isolates and 3 reference strains were tested, including 250 C. albicans and 19 C. dubliniensis strains. All C. albicans isolates tested exhibited significant growth on hypertonic Sabouraud broth up to 96 h, while, all C. dubliniensis isolates did not exhibit any visually detectable growth during the same period.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12052633     DOI: 10.1016/s0732-8893(02)00368-1

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  23 in total

1.  Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different phenotypic methods.

Authors:  Maria Eugenia Bosco-Borgeat; Constanza Giselle Taverna; Susana Cordoba; Maria Guillermina Isla; Omar Alejandro Murisengo; Wanda Szusz; Walter Vivot; Graciela Davel
Journal:  Mycopathologia       Date:  2011-07-13       Impact factor: 2.574

Review 2.  Candida identification: a journey from conventional to molecular methods in medical mycology.

Authors:  Mohammad Zubair Alam; Qamre Alam; Asif Jiman-Fatani; Mohammad Amjad Kamal; Adel M Abuzenadah; Adeel G Chaudhary; Mohammad Akram; Absarul Haque
Journal:  World J Microbiol Biotechnol       Date:  2014-01-01       Impact factor: 3.312

3.  Candida dubliniensis screening using the germ tube test in clinical yeast isolates and prevalence of C. dubliniensis in Korea.

Authors:  Tae-Hyoung Kim; Bo-Rae G Park; Hye Ryoun Kim; Mi-Kyung Lee
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

4.  Methods of Candida dubliniensis identification and its occurrence in human clinical material.

Authors:  Martina Mahelová; Filip Růžička
Journal:  Folia Microbiol (Praha)       Date:  2017-05-17       Impact factor: 2.099

5.  The usefulness of DNA sequencing after extraction by Whatman FTA filter matrix technology and phenotypic tests for differentiation of Candida albicans and Candida dubliniensis.

Authors:  Nuri Kiraz; Yasemin Oz; Huseyin Aslan; Hamza Muslumanoglu
Journal:  Mycopathologia       Date:  2014-01-17       Impact factor: 2.574

6.  Species distribution and virulence factors of Candida spp. isolated from the oral cavity of kidney transplant recipients in Brazil.

Authors:  Guilherme Maranhão Chaves; Mariana Guimarães Diniz; Walicyranison Plinio da Silva-Rocha; Luanda Bárbara Ferreira Canário de Souza; Libia Augusta Maciel Gondim; Maria Angela Fernandes Ferreira; Terezinha Inez Estivalet Svidzinski; Eveline Pipolo Milan
Journal:  Mycopathologia       Date:  2013-03-29       Impact factor: 2.574

7.  Isolation of Candida dubliniensis for the first time in Cali, Colombia, and its identification with phenotyping methods.

Authors:  María Inés Alvarez; Blanca Lynne Suárez; Luz Dary Caicedo
Journal:  Mycopathologia       Date:  2008-07-12       Impact factor: 2.574

8.  Hypertonic sabouraud dextrose agar as a substrate for differentiation of Candida dubliniensis.

Authors:  Oncü Akgül; Nilgün Cerikçioğlu
Journal:  Mycopathologia       Date:  2009-02-20       Impact factor: 2.574

9.  Differentiation of Candida dubliniensis from Candida albicans on rosemary extract agar and oregano extract agar.

Authors:  Erico Silva de Loreto; Patrícia Pozzatti; Liliane Alves Scheid; Deise Santurio; Janio Morais Santurio; Sydney Hartz Alves
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

10.  Epidemiology and antifungal susceptibilities of yeasts causing vulvovaginitis in a teaching hospital.

Authors:  Soledad Gamarra; Susana Morano; Catiana Dudiuk; Estefanía Mancilla; María Elena Nardin; Emilce de Los Angeles Méndez; Guillermo Garcia-Effron
Journal:  Mycopathologia       Date:  2014-07-09       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.